JNK/SAPK signalling is essential for efficient reprogramming of human fibroblasts to induced pluripotent stem cells by Neganova A et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This work is licensed under a Creative Commons Attribution 4.0 International License 
 
 
Newcastle University ePrints - eprint.ncl.ac.uk 
 
Neganova A, Shmeleva E, Munkley J, Chichagova V, Anyfantis G, Anderson R, 
Passos AJ, Elliott DJ, Armstrong L, Lako M. JNK/SAPK signalling is essential for 
efficient reprogramming of human fibroblasts to induced pluripotent stem 
cells. Stem Cells 2016, DOI: 10.1002/stem.2327 
 
 
Copyright: 
© 2016 The Authors STEM CELLS published by Wiley Periodicals, Inc. on behalf of AlphaMed Press. This is 
an open access article under the terms of the Creative Commons Attribution License, which permits 
use, distribution and reproduction in any medium, provided the original work is properly cited. 
DOI link to article: 
http://dx.doi.org/10.1002/stem.2327  
Date deposited:   
08/03/2016 
  
JNK/SAPK Signaling is Essential for Efficient
Reprogramming of Human Fibroblasts to
Induced Pluripotent Stem Cells
IRINA NEGANOVA,a EVGENIJA SHMELEVA,a JENNIFER MUNKLEY,a VALERIA CHICHAGOVA,a
GEORGE ANYFANTIS,a RHYS ANDERSON,b JOAO PASSOS,b DAVID J. ELLIOTT,a
LYLE ARMSTRONG,a MAJLINDA LAKOa
Key Words. JNKs • SAPK • MKK4 • MKK7 • hiPSC • hESC
ABSTRACT
Reprogramming of somatic cells to the phenotypic state termed “induced pluripotency” is
thought to occur through three consecutive stages: initiation, maturation, and stabilisation.
The initiation phase is stochastic but nevertheless very important as it sets the gene expres-
sion pattern that permits completion of reprogramming; hence a better understanding of this
phase and how this is regulated may provide the molecular cues for improving the reprogram-
ming process. c-Jun N-terminal kinase (JNK)/stress-activated protein kinase (SAPKs) are stress
activated MAPK kinases that play an essential role in several processes known to be impor-
tant for successful completion of the initiation phase such as cellular proliferation, mesenchy-
mal to epithelial transition (MET) and cell cycle regulation. In view of this, we postulated that
manipulation of this pathway would have significant impacts on reprogramming of human
fibroblasts to induced pluripotent stem cells. Accordingly, we found that key components of
the JNK/SAPK signaling pathway increase expression as early as day 3 of the reprogramming
process and continue to rise in reprogrammed cells throughout the initiation and maturation
stages. Using both chemical inhibitors and RNA interference of MKK4, MKK7 and JNK1, we
tested the role of JNK/SAPK signaling during the initiation stage of neonatal and adult fibro-
blast reprogramming. These resulted in complete abrogation of fully reprogrammed colonies
and the emergence of partially reprogrammed colonies which disaggregated and were lost
from culture during the maturation stage. Inhibition of JNK/SAPK signaling resulted in reduced
cell proliferation, disruption of MET and loss of the pluripotent phenotype, which either singly
or in combination prevented establishment of pluripotent colonies. Together these data pro-
vide new evidence for an indispensable role for JNK/SAPK signaling to overcome the well-
established molecular barriers in human somatic cell induced reprogramming. STEM CELLS
2016; 00:000—000
SIGNIFICANCE STATEMENT
Our research group has a long standing interest in understanding the molecular mechanisms
underpinning the induction of pluripotency which may be essential for enhancing the reprog-
ramming process. In this manuscript, we have focused our attention on the c-Jun N-terminal
kinase (JNK) signaling, a pathway which has been extensively studied in somatic and cancer
cells, but it has been relatively unexplored in human pluripotent stem cells. Through a combi-
nation of techniques, we have been able to show that JNK/SAPK signaling is indispensable for
overcoming several well described molecular barriers occurring in the initial stage of reprog-
ramming, thus providing for the first time clear insights on the role of this pathway on human
somatic cell induced reprogramming.
INTRODUCTION
Since 2007, it has been possible to reprogram
human somatic cells back to an embryonic
stem cell (ESC) like stage via introduction of
four transcription factors, namely OCT3/4,
SOX2, KLF4, and c-MYC (referred as OSKM;
[1]). The reprogrammed cells termed human
induced pluripotent stem cells (hiPSCs), akin to
human embryonic stem cells (hESCs) are char-
acterized by the ability to proliferate indefi-
nitely and have the potential to give rise to all
cell types found in the adult organism [2]. The
aforementioned pluripotency factors have also
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been implicated in the initiation of tumorigenesis in various
tissues [3–5] and are considered as potent oncogenes. The
risk associated with the introduction of these oncogenes in
normal human somatic cells is the likely activation of anti-
oncogenic pathways through a process named oncogenic
stress which can often result in cell cycle arrest as a means of
protection from tumorigenesis [6]. Activation of cell cycle
arrest, p53 activation and reduced cellular proliferation have
been described as molecular barriers to efficient reprogram-
ming [7–9]. In view of these findings, we hypothesised that
transduction of dermal skin (Fibroblasts: Lonza Group Ltd,
Basel, Switzerland; Lonza:http://www.lonza.com/) with OSKM
would activate oncogenic stress and induce growth arrest
thus providing an additional barrier to reprogramming. Hence
inhibition of key sensors of this pathway could provide useful
targets for removing this barrier and increasing its efficiency.
Stress activated MAP kinase signaling pathways are impor-
tant mediators of cellular responses to intra- and extracellular
signals such as growth factors, hormones, and environmental
stresses. These pathways consist of triple kinase cascades
comprising the MAP kinases which are phosphorylated and
activated by MAP kinase kinases (MKKs) and then further
phosphorylated and activated by MAP kinase kinase kinases
(MKKKs) [10]. In mammals, three distinct MAP kinase path-
ways have been identified resulting in activation of ERK, c-Jun
N-terminal kinase (JNK) and p38 [10]. One of the key sensors
of oncogenic stress is the JNK signaling pathway which
responds by phosphorylating and stabilising p53 via its down-
stream mediator MKK7 [11]. The JNK pathway, also named
stress-activated protein kinase pathway (SAPK) is essential for
providing a cellular response to extracellular changes such as
ultraviolet and reactive oxygen species induced damage,
mechanical stress and osmolarity changes. For the JNK/SAPK
pathway 14 different MKKs have been described to date [12].
MKK7 exclusively activates JNKs and MKK4 is unique in its
ability to phosphorylate and activate two MAP kinase groups:
JNKs and p38. Both MKK4 and MKK7 are responsible for phos-
phorylation of JNK/SAPKs at Tyrosine (Tyr) and Threonine
(Thr) residues located at the activation loop. In murine
embryonic stem cells (mESCs), MKK4 is shown to phosphoryl-
ate JNK/SAPKs at Tyr 185 residue, while MKK7 phosphorylates
the Thr 183 residue, and together they cause dual phospho-
rylation of JNK/SAPKs, thus leading to its optimal
activation [13].
Most of the data on JNK/SAPK signaling and activation of
its targets has been obtained from work performed in
somatic and cancer cells [14]; however in the last few years
there have been a number of publications describing the
role of this signaling pathway during embryonic development
and in ESC function. Some of these have shown that MKK4
and MKK7 null mice die before E.12.5, highlighting the
necessity of JNK/SAPK signaling pathway during embryonic
development and suggesting that other pathways cannot
substitute for MKK4 and MKK7 [15, 16]. Furthermore, JNK1
and JNK2 have been shown to play a negative role in the
reprogramming of murine fibroblasts by suppressing Klf4
activity [17]. In contrast, hESCs are characterized by high lev-
els of JNK/SAPK activity which is important for maintenance
of pluripotency; however a role for this signaling pathway
during reprogramming of human somatic cells has not been
described previously and forms the main focus of this manu-
script. We report herein that transduction of human fibro-
blasts with OSKM (both as single and polycistronic Sendai
based viruses) induces the activation of JNK/SAPK signaling
during the initiation and maturation stage of reprogramming.
Downregulation of JNK/SAPK with a specific chemical inhibi-
tor or by RNA interference (RNAi) leads to the emergence of
only partially reprogrammed colonies which disaggregate
and are lost during the maturation stage of reprogramming.
Our data suggest that JNK/SAPK signaling plays an important
role in several key processes that are shown to be important
during cellular reprogramming namely the induction of mes-
enchymal to epithelial transition (MET), activation of cellular
proliferation as well the maintenance of the pluripotent phe-
notype. Hence lack of hiPSC colonies and loss of partially
reprogrammed cells can be attributed to one or more of
these three cellular processes which are tightly regulated by
JNK/SAPK signaling.
MATERIALS AND METHODS
hiPSC Generation
Cyto Tune.1-iPS reprogramming kit (A13780-01, Invitrogen)
and Cyto Tune-iPS 2.0 Sendai reprogramming kit (A16517,
Invitrogen:https://www.thermofisher.com/order/catalog/prod-
uct/A16517) were used for hiPSC derivation as described in a
recent publication by our group [18]. CytoTune-EmGFP Sendai
Fluorescence Reporter (A16519, Invitrogen:https://www.ther-
mofisher.com/order/catalog/product/A16519) was used as
control.
Cell Culture
Human neonatal and adult dermal fibroblasts were purchased
from Lonza and were cultured in 6 or 12 well tissue culture
plates (Iwaki ) in Iscove’s Modified Dulbecco’s Medium, 10%
fetal calf serum (PAA), 2mM L-glutamine (PAA), 1% nonessen-
tial amino acids (PAA), 100 units/ml penicillin (PAA) at 378C
and 5% CO2. Human ESC (H9) and hiPSC lines were cultured
under feeder free conditions using (Matrigel: (BD Biosciences)
, Oxford, UK http://www.bd.com/uk/) as coating substrate (BD
Biosciences) and mTESR1 media (Stem Cell Technologies, Cam-
bridge , UK, http://www.stemcell.com/).
RNA Interference
Stable downregulation of MKK4, MKK7 and JNK1 in human
neonatal and adult fibroblasts was carried out using lentiviral
based MISSION shRNAs (MKK7: TRCN0000315390 MAP2K7
MISSION shRNA; MKK4: TRCN0000039914 MAP2K4 MISSION
shRNA and JNK1: TRCN0000342626 MAPK8) according to the
manufacturer’s protocol (Sigma). Briefly, exponentially growing
fibroblasts cultures (70%–80% confluent) were transduced
with lentiviral particles (MOI5 2; 1.63 104 cells). Puromycin
selection (5mg/ml) was used to select stable clones. Replace-
ment of media with fresh puromycin containing media was
performed every 2-3 days until resistant colonies were
identified.
Statistical Analysis
t test analysis was used to assess differences between control
and RNAi groups. The results were considered significant if
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p < .05. For additional details on materials and methods,
please refer to Supporting Information Annex.
RESULTS
JNK/SAPKs Kinases are Activated During the Course of
Reprogramming
To understand the role of JNK/SAPKs during the generation of
hiPSCs we assessed the expression of JNK1 and JNK2 and
their upstream activators MKK4 and MKK7 in two different
primary dermal skin fibroblasts (Neonatal/Neo1 and Adult/
Ad3), several hiPSCs clones derived therefrom (Fig. 1A, 1B,
Supporting Information Fig. 1B) and hESCs (H9). Human ESCs
are characterised by high levels of JNK/SAPK activity which
has been shown to be important for maintenance of the plu-
ripotent stem cell state [19]. In accordance with this, we
found the highest levels of mRNA JNK1 expression in hESCs
when compared to several hiPSCs clones derived from two
adult fibroblast samples (Fig. 1A, 1B, Supporting Information
Fig. 1B); however these differences were not maintained at
the protein level across the iPSC clones examined (Fig. 1B).
We also observed that neonatal fibroblasts had lower expres-
sion of all four kinases examined when compared to adult
fibroblasts (Fig. 1A, 1B). These differences were in part main-
tained in the respective hiPSC lines with the adult derived
hiPSC clones showing higher expression of JNK1 when com-
pared to neonatal derived hiPSCs at both transcript and pro-
tein level (Fig. 1A, 1B, Supporting Information Fig. 1A, 1B).
Transduction of OSKM caused a significant increase in
JNK1 expression in adult fibroblasts and a dual increase in
JNK1 and JNK2 expression in neonatal fibroblasts as early as
day 3 of reprogramming (Fig. 1A-1C, Supporting Information
Fig. 1A). This was followed by an increase in expression of
pSAPK [Tyr 185/Thr 183SAPK)] from day 6 to day 21 in neona-
tal fibroblasts (Fig. 1B, 1C) and from day 12 to day 21 in adult
fibroblasts (Fig. 1B, Supporting Information Fig. 1A). The
expression of pSAPK (Ser63) was increased as early as day 3
continuing till day 21 of reprogramming in both neonatal and
adult fibroblasts (Fig. 1B, 1C, Supporting Information Fig. 1A).
Together these data suggest an increased JNK/SAPK activity
during the initiation and maturation stage of reprogramming.
To determine how the four transcription factors (OSKM)
individually contribute to JNK/SAPK activation during reprog-
ramming, we performed transduction with each single factor
in neonatal fibroblasts and substituted the rest of the factors
with an equivalent number of control-GFP virus particles (Sup-
porting Information Fig. 1C). Transduction with OCT4, KLF4
and c-MYC contributed mostly to an increase in JNK2 expres-
sion, while introduction of SOX2 increased both JNK1 and
JNK2 expression with a preference for JNK1. Transduction with
control viral particles alone did not lead to increased JNK1/
JNK2 expression or their phosphorylated form (data not
shown), indicating that activation of JNK/SAPK pathway during
reprogramming is not related to the transduction event, but
specifically to introduction of OSKM in somatic cells.
To further confirm the increase in p-JNK/SAPK expression
at a cellular level, we used flow cytometric analysis as
described previously [20]. This enabled us to follow three cel-
lular subpopulations during the course of reprogramming;
fully reprogrammed cells (TRA-1-601CD44-), partially reprog-
rammed cells (TRA-1-601CD441) and fibroblasts (TRA-1-60-
CD441; Fig. 1D, 1E). pSAPK was expressed in all three subpo-
pulations (Fig. 1F, 1G). It is interesting to note that the
partially reprogrammed cells showed the highest percentage
of pSAPK1 expressing cells; however this declined toward the
end of the reprogramming period (Fig. 1G). Furthermore, the
percentage of pSAPK expressing cells increased in the fully
reprogrammed subpopulation from day 14 to day 18 (Fig. 1G)
then decreased by day 28, corroborating the Western blotting
analysis (Fig. 1B, 1C, Supporting Information Fig. 1A). We
obtained the same profile of emergence of the three cellular
subpopulations and the same trend of pSAPK activation (Sup-
porting Information Fig. 2A, 2B) upon application of a polycis-
tronic Sendai vector (Cytotune 2.0), demonstrating that
activation of JNK/SAPK is independent of hiPSC transduction
protocol. Together these data suggest an important role for
the activity of JNK/SAPK in fully reprogrammed cells during
the maturation stage of reprogramming.
Inhibition of JNK/SAPK Activation with Chemical
Inhibitors Causes Disaggregation and Loss of hiPSC
Colonies During Maturation Stage
To test the function of JNK/SAPKs in generation of hiPSCs we
used a small molecule SP600125, which has been shown to
significantly inhibit expression of all three JNK genes namely
JNK1, JNK2, and JNK3 [21]. Our data show that 5 mM
SP600125 (named SAPKi thereafter) is sufficient to downregu-
late the expression of JNK1 and JNK2 in hESCs (Fig. 2A) cor-
roborating previous data published in mouse ESCs [22]. To
investigate the impact of JNK/SAPK inhibition in the reprog-
ramming process, we used SAPKi for 24 hours at different
time points as summarized in Figure 2B and Supporting Infor-
mation Figure 3. Our results indicate that application of SAPKi
had a detrimental effect on hiPSC generation regardless of
the time of application, for no hiPSC colonies were obtained
at the end of the transduction period from either adult or
neonatal fibroblasts (Fig. 2F-2J, Supporting Information Fig. 3).
In all cases, flow cytometric analysis indicated a significant
decrease in the percentage of emerging hiPSCs (TRA-1-
601CD44-; Fig. 2B-2D). Furthermore, SAPKi application
affected the TRA1-601 populations specifically (partially
reprogrammed and fully reprogrammed distinguished by pres-
ence or absence of CD44 respectively, Fig. 2C, 2D) as no
reduction in the TRA-1-60-CD441 population of dermal skin
fibroblasts was observed (Fig. 2D). In control cultures (treated
with DMSO vehicle only) we observed morphological changes
(cells rounding up, starting to group together and showing
morphology typical of pluripotent stem cells) which led to the
emergence of hiPSC colonies with clear compact edges as
early as day 16 (Fig. 2E, Supporting Information Fig. 3). In
SAPKi treated cultures, we observed formation of colonies
with morphology typical of partially reprogrammed cells; how-
ever most of these started to disintegrate as early as day 16
(Fig. 2E, 2D) and by day 18 all these partially reprogrammed
colonies were lost from the culture (Fig. 2E).Thus, formation
of hiPSCs colonies showing morphological features of pluripo-
tent stem cells was not observed in the presence of SAPKi.
Assessment of total colony number at the mid-point (day 16)
as well as hiPSC colonies at day 28 (identified by alkaline
phosphatase staining) corroborated the morphological and
flow cytometric analysis and indicated no viable hiPSC
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colonies upon application of SAPKi (Fig. 2F, 2J), suggesting
that JNK/SAPK activity is important for generation of hiPSCs
colonies.
MKK4, MKK7 and JNK1/SAPK1 are Indispensable for
hiPSC Generation
Application of chemical inhibitors can induce transient down-
regulation of JNK/SAPK which may mask some of their effects
on cellular reprogramming. To investigate if permanent down-
regulation of JNK/SAPK yields the same or more extensive
impact we generated stable cell lines of neonatal and adult
fibroblasts in which MKK4, MKK7 and JNK1/SAPK1 (JNK1)
were downregulated by shRNA. Successful downregulation of
each of the three genes was confirmed by qRT-RCR at the
mRNA level (Fig. 3A, 3B) and protein level (Fig. 3C). We
observed that downregulation of MKK4, MKK7 and JNK1
resulted in a more effective repression of downstream targets
in neonatal fibroblasts when compared to their adult
Figure 1.
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counterparts (Fig. 3D, 3E). In part this may be explained by
higher expression of these kinases in adult fibroblasts (Fig.
1A, 1B) and possibly by the existence of additional compensa-
tory mechanisms.
Morphological observation of MKK4, MKK7 and JNK1
shRNA treated fibroblasts revealed differences between neo-
natal and adult cells (Supporting Information Fig. 4A, 4B).
Neonatal fibroblasts continued to proliferate very slowly after
passage 3, thus corroborating previously published literature
reporting reduced proliferation and G2/M phase arrest in
mouse embryonic fibroblasts [16]. We also observed that
MKK4, MKK7 and JNK1 shRNA adult fibroblasts stopped
growing after the first passage and demonstrated spindle
shape and flattened morphology similar to senescent cells
[23]. Despite this, we were unable to detect activation of
senescence markers (b-gal, p15, p16, p19) in either neonatal
or adult fibroblasts deficient in JNK signaling (data not
shown).
We performed transduction of neonatal and adult control
and MKK4, MKK7, JNK1 shRNA fibroblasts with OSKM and as
in the case of SAPKi we observed greatly reduced numbers
of emerging hiPSCs (TRA1-601CD44-) and partially reprog-
rammed cells (TRA-1-601CD441; Fig. 4A, 4B). Quantitative
RT-PCR analysis at 7 days post transduction indicated that
downregulation of MKK4, MKK7 and JNK1 shRNA was main-
tained (Supporting Information Fig. 5). On a morphological
level, partially reprogrammed cells were detected from neo-
natal fibroblasts transduced with JNK1, MKK4 and MKK7
shRNA as early as day 14 (Fig. 4B); however these started to
disaggregate by day 18, corroborating the data observed with
SAPKi. Transduced adult fibroblasts exhibited a few minor
morphological changes during the first 10 days of reprogram-
ming; however they did not form either partially reprog-
rammed or fully reprogrammed colonies (data not shown).
The same profile of colony disaggregation and a significant
reduction in the percentage of true emerging hiPSC (TRA1-
601CD44-) was observed when JNK1, MKK4 and MKK7
shRNA neonatal fibroblasts were reprogrammed with a Sen-
dai polycistronic vector (Cytotune 2.0; Supporting Information
Fig. 6). To understand whether the absence of a true hiPSCs
from JNK1 shRNA transduced cells was associated with cellu-
lar differentiation we performed qRT-PCR analysis of the
expression of three germ layer differentiation markers on
cells collected from remaining colonies at day 18. This analy-
sis indicated the upregulation of al differentiation markers
examines apart from FGF5, suggesting that the onset of dif-
ferentiation can be an additional reason for the absence of
hiPSC from JNK1 shRNA cells (Fig. 4C). In accordance with
the above results, no alkaline phosphatase positive hiPSC col-
onies were obtained from either neonatal or adult fibro-
blasts, indicating that MMK4, MKK7 and JNK1 are
indispensable for successful reprogramming.
Impact of JNK/SAPK Downregulation on Pluripotent
Stem Cells
To understand the deleterious effect of JNK/SAPK downregula-
tion during the reprogramming process, we inhibited JNK/
SAPK pathway in hESC via administration of SAPKi. Human
ESCs have been characterized by high JNK activity [24] and
inhibition of this pathway with chemical inhibitors has been
shown to result in cellular differentiation, decreased OCT4
and NANOG expression [19]. Consistent with published
results, we observed loss of typical pluripotent stem cell mor-
phology (Supporting Information Fig. 7A) downregulation of
OCT4 expression (Supporting Information Fig. 7B) and an
increase in KLF4 expression, corroborating previously pub-
lished data on mESCs [17]. Also, in agreement with previous
reports [17] we found increased expression of differentiation
markers characteristic for neuroectoderm (SOX1, NESTIN),
trophoectoderm (CDX2) and primitive endoderm (AFP; Sup-
porting Information Fig. 7C). No change in cell survival was
observed as a result of SAPKi application (data not shown);
however an increase in G1 phase at the expense of S phase
was observed upon cell cycle analysis by flow cytometry (Sup-
porting Information Fig. 7D). Together these data suggest that
JNK activity is required for the maintenance of pluripotency;
hence its downregulation during the reprogramming process
can provide one of the underlying factors for the emergence
of colonies with partially reprogrammed phenotype and lack
of fully reprogrammed hiPSCs.
Figure 1. JNK/SAPK signaling is activated during the initiation and maturation stage of reprogramming. (A): Real-time PCR analysis of
MKK4, MKK7, JNK1 and JNK2 expression in H9 (p36), neonatal human fibroblasts (Neo1), adult human fibroblasts (Ad3) and human
induced pluripotent stem cell (hiPSC) generated therefrom (Neo1cl1iPSC and Ad3cl1iPSC, respectively). Data represent relative expres-
sion to GAPDH and normalized against H9. Data are presented as mean6 SEM. (B): Western blot analysis showing expression of MKK4,
MKK7, JNK/SAPKs, pSAPK(Thr183/Tyr185) and pSAPK (Ser63) in hESC (H9), human neonatal fibroblasts (Neo1), human adult fibroblasts
(Ad3) at Day 0 and hiPSC derived therefrom (Neo1cl1iPSC and Ad3cl1iPSC, respectively). (C): Western blot analysis of protein expression
of MKK4, MKK7, JNK/SAPKs, pSAPK(Thr183/Tyr185) and pSAPK (Ser63) during the reprogramming of Neo1 fibroblasts. Days of transduc-
tion are indicated as D3—Day 3 and so on, correspondently. GAPDH served as loading control. Images are representative of at least
three independent experiments. (D): Flow cytometric analysis of the distribution of TRA1-601/CD44-, TRA1-601/CD441 and TRA1-60-/
CD441 populations during time course of reprogramming of neonatal (Neo1) and adult fibroblasts (Ad3). This is a representative exam-
ple of at least three independent experiments. (E): Neo1 fibroblasts undergoing reprogramming were sorted in all four different subpo-
pulation by FACS at day 13 of reprogramming and replated. The resulting colonies were stained by alkaline phosphatase at day 28.
TRA1-601 /CD44– cells formed numerous AP1 colonies (upper panel), while TRA1-601/CD441 cells (lower panel) generated partly
reprogrammed colonies. (F): Representative examples of flow cytometric analysis showing the distribution of pSAPK1 cells among
TRA1-601/CD44-, TRA1-601/CD441 and TRA1-60-/CD441 populations at day 10 of reprogramming of Neo1 fibroblasts. (G): Graphic
representation of the percentage of p-SAPK1 cells at different cells populations (TRA1-601/CD44-, TRA1-601/CD441 and TRA1-60-/
CD441) during the reprogramming of Neo1 fibroblasts assessed by flow cytometric analysis. Data are presented as mean6 SEM. Abbre-
viations: FACS, Fluorescence-activated cell sorting; hESC, human embryonic stem cell; iPSC, induced pluripotent stem cell; JNK, c-Jun N-
terminal kinase; MKK, MAP kinase kinases; SAPK, stress-activated protein kinase.
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A recent report has suggested that heat shock treatment
of hESC results in activation of SAPK/JNK signaling and
reduced expression of OCT4 due to increased binding of heat
shock factor 1 to the OCT4 promoter [25]. Although this find-
ing may appear contradictory to our data presented above,
we would like to point out that the difference may be due to
physiological stimuli. While hESC data presented in this work
were collected from normal culture conditions (378C and nor-
moxic oxygen levels), the Buyn et al. findings relate to the
“heat shock” conditions which represent stress conditions and
are likely to affect many other signaling pathways in hESC in
addition to the JNK/SAPK pathway.
Figure 2. Application of JNK/SAPKs inhibitor (SP60015) abrogates human induced pluripotent stem cell generation. (A): Western blot
analysis of JNK/SAPKs downregulation by SP60015 (SAPKi) in hESCs (H9). GAPDH used as a loading control. Images are representative of
at least three independent experiments. (B): Schematic representation of inhibitor application (SAPKi) at day 8 during the reprogram-
ming process. (C): Graphic representation of flow cytometric analysis data (day 13) indicating a significant impact of SAPKi application
(applied at day 8 for 24 hours) on the percentage of TRA1-601/CD44- cells. Results are presented as mean6 SEM (n5 3). (D): Graphic
representation of flow cytometric analysis data (day 13) demonstrating a significant impact of SAPKi application on TRA1-601/CD44-
and TRA1-601/CD441 subpopulations generated during reprogramming of Neo1 fibroblasts. Results are presented as mean6 SEM
(n5 3). (E): Phase–contrast observation showing the morphology of partially reprogrammed colonies arising during the reprogramming
of Neo1 and Ad3 fibroblasts treated with DMSO or SAPKi for 24 hours at day 8, scale bars5 100 mm. (F): Graphic representation of total
colony numbers at day 16 and 28 of reprogramming in SAPKi and DMSO treated Neo1 and Ad3 fibroblasts. Data are presented as mean-
6 SEM (n5 3). (J): Alkaline phosphatase staining at day 28 confirmed the absence of true AP1 colonies from neonatal and adult fibro-
blasts undergoing reprogramming and treated with SAPKi at day 8 of transduction for 24 hours. (C, D, F): *, p< .05. Abbreviations: AP,
Alkaline phosphatase; DMSO, Dimethyl sulfoxide; FCM, Flow Cytometric and Morphological Analysis; JNK, c-Jun N-terminal kinase; SAPK,
stress-activated protein kinase.
6 An Indispensable Role for JNK/SAPK Signaling in the Reprogramming of Human Fibroblasts
VC 2016 The Authors STEM CELLS published by Wiley Periodicals,
Inc. on behalf of AlphaMed Press STEM CELLS
Impact of JNK/SAPK Downregulation on Cellular
Proliferation and Cell Cycle Regulation in Somatic Cells
To better understand the changes induced in neonatal and
adult fibroblasts by downregulation of the JNK/SAPK pathway,
we administered SAPKi to culture media. Similarly to our
observations obtained with JNK1 shRNA (Supporting Informa-
tion Fig. 4), we observed that SAPKi treated fibroblasts
became more elongated, flattened and in some cases spindle
shaped (Supporting Information Fig. 7E). Growth curve analy-
sis also indicated a slower rate of proliferation in SAPKi
treated fibroblasts (Supporting Information Fig. 7F) supporting
previously published data [26]. This was further confirmed by
cell cycle analysis which demonstrated that downregulation of
JNK/SAPKs resulted in cell accumulation in G1 phase at the
Figure 3. Assessment of MKK4, MKK7 and JNK1 downregulation in neonatal (A) and adult (B) fibroblasts by real-time quantitative RT-
PCR analysis. Data represent relative expression to GAPDH and normalized against Control shRNA. Results are presented as avera-
ge6 SEM (n5 3). t test analysis was carried out to assess differences in gene expression between the control and shRNA groups. West-
ern blot analysis of MKK4, MKK7 and SAPK expression in Control shRNA and MKK4 shRNA, MKK7 shRNA and JNK1 shRNA neonatal cells
(C). Analysis of the crosstalk between upstream and downstream MKK4/MKK7-JNK1 signaling pathways in neonatal (D) and adult fibro-
blasts (E) revealed by real-time quantitative RT-PCR analysis. Results are presented as average6 SEM (n5 3). *, p< .05. Abbreviations:
JNK, c-Jun N-terminal kinase; MKK, MAP kinase kinases; SAPK, stress-activated protein kinase; shRNA, short hairpin RNA.
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expense of S phase cells (Supporting Information Fig. 7G).
Western blot analysis also indicated the downregulation of
the downstream target, c-Jun known to be important for cel-
lular proliferation (Supporting Information Fig. 7H).
To understand the molecular changes underpinning JNK/
SAPK inhibition, we performed quantitative RT-PCR analysis of
JNK target genes involved in cellular proliferation, namely c-
Jun, E2F2 and ATF2. Since the effect of SAPKi may be tran-
sient, we performed this analysis on neonatal and adult fibro-
blasts treated with MKK4, MKK7 and JNK1 shRNA described in
Figure 3A and 3B. We found that c-JUN, ATF2 and E2F2 were
significantly downregulated in all cases (Fig. 5A). Of interest
are also the findings that key cyclin dependent kinases (CDK6,
CDK2 and CDK1) were downregulated in at least one of the
shRNA treated samples. Furthermore CCNB1, a key cyclin
involved in both G1/S and G2/M regulation was downregu-
lated in MKK4, MKK7 and JNK1 shRNA treated samples, while
Cyclin D1 (CCND1) was downregulated in MKK4 and JNK1
shRNA cells (Fig. 5B). Flow cytometry cell cycle analysis
revealed that in contrast to fibroblasts treated with control
shRNA, which demonstrated a characteristic somatic cell cycle
distribution at day 0, MKK4, MKK7 and JNK1shRNA treated
fibroblasts showed an increased cell accumulation at G1
phase at the expense of S and G2/M phase prior to reprog-
ramming (day 0) and at day 7 of reprogramming (Fig. 5C).
Together these data suggest an impaired cell cycle regulation
and proliferation as a result of JNK/SAPK downregulation.
Importance of JNK/SAPK Signaling for the MET
MET is an important process during somatic cell reprogram-
ming and is orchestrated by the suppression of pro-epithelial
to mesenchymal transition (EMT) signals and activation of an
epithelial signature in reprogrammed cells [27]. During this
process, two of the key reprogramming factors SOX2 and
OCT4 suppress the EMT mediator SNAIL, while KLF4 induces
epithelial gene expression including E-cadherin [27]. Ultra-
structural visualization of this process has shown that until
day 6 of reprogramming, human fibroblasts retain their mes-
enchymal characteristics. The MET occurs between days 6 and
12 and this is followed by maturation of the epithelial pheno-
type from day 12 to day 18 [28]. Although traditionally JNKs
have been thought to be activated in response to apoptotic,
proliferation and stress signals, more recently it has been
shown that they can also act as cell junction regulators [29]
and can be involved in cell migration which is tightly linked to
dynamic formation as well as dissolution of cell-cell junctions
[29, 30]. Given the importance of MET in hiPSC formation we
asked whether inhibition of JNK/SAPK signaling leads to loss
of E-cadherin expression-dependent adhesion, followed by
loss of cell-to-cell communication resulting in disintegration of
partially reprogrammed colonies and their loss from culture.
Immunocytochemical analysis of OSKM treated control fibro-
blasts indicated formation of a bright network of E-cadherin
and b-catenin plasma membrane staining in TRA-1-60 positive
cells (Fig. 6A, 6B), indicating formation of adherent junctions
between the cells. In contrast, E-cadherin and b-catenin stain-
ing was observed in very few of the cells present in the par-
tially reprogrammed TRA-1-60 positive colonies obtained from
reprogramming of JNK1 shRNA treated fibroblasts (Fig. 6A,
6B). Furthermore, the bright E-cadherin and b-catenin net-
works which ensure the cell-cell adhesion and communication
were missing in reprogrammed JNK1 shRNA treated fibro-
blasts. Assessment of N-cadherin expression, a marker of
fibroblasts that fail to undergo MET and further convert into
hiPSC [31] indicated a higher number of expressing cells in
JNK deficient cells (Fig. 6C), further supporting the disruption
of MET during the reprogramming of JNK deficient samples.
Quantitative RT-PCR analysis indicated downregulation of epi-
thelial marker (E-cadherin) and upregulation of mesenchymal
markers (SNAIL, N-cadherin, TWIST, VIMENTIN, ZEB1 and
SLUG) under both Cytotune 1 and 2 Sendai reprogramming
(Fig. 6D, Supporting Information Fig. 8), further supporting
the disruption of MET during the reprogramming of JNK defi-
cient samples.
DISCUSSION
In this manuscript, we investigated the expression of key com-
ponents of JNK/SAPK signaling and found that this pathway is
activated as early as day 3 of reprogramming with both par-
tially reprogrammed cells (TRA-1-601CD441) and fully
reprogrammed cell populations (TRA-1-601CD44-) showing an
increase in the number of pSAPK expressing cells until day 18,
regardless of the reprogramming protocol used. In contrary to
our first expectations, we found that inhibition of JNK/SAPK
signaling pathway either by chemical inhibitors or RNAi medi-
ated downregulation of MKK4, MKK7 or JNK1 resulted in the
complete abrogation of hiPSC colony formation and emer-
gence of partially reprogrammed cells which were lost during
the maturation stage of reprogramming. Together these data
highlight the importance of this signaling pathway in human
somatic cell induced reprogramming which to the best of our
knowledge has not been reported previously. In contrast to
our findings, it has been reported that Jnk1-/- and Jnk2-/-
murine fibroblasts exhibit a greater potency for reprogram-
ming due to increased Klf4 activity which is phosphorylated
by Jnk1 and Jnk2 through inhibitory phosphorylation at Thr
residues 224 and 225 [17]. These differences in the role of
JNK signaling during the reprogramming of mouse versus
human somatic cells can reflect different modes of actions for
this pathway in each species; however this needs to be inves-
tigated further. We were also surprised to see the lack of
functional redundancy between various components of key
signaling molecules involved in JNK signaling as downregula-
tion of MKK4, MKK7 and JNK1 in fibroblasts led in all cases to
complete absence of hiPSC colonies. Notwithstanding this, we
would like to point out that all single component downregula-
tion by RNAi led to further changes in the expression of addi-
tional components of this pathway (e.g., MKK4 shRNA
resulted in downregulation of MKK7 and JNK1) and/or parallel
pathways such as p38, thus outlining the complexity of regu-
lation of this pathway which has been reported previously
and must be taken into account when investigating the func-
tion of separate signaling components [32–34]. Furthermore,
we observed some differences in the expression of key com-
ponents of JNK/SAPK signaling between neonatal and adult
fibroblasts as well as their response to JNK/SAPK inhibition
which indicates differences in the mode of operation of this
pathway in these two cell types. Nevertheless, the activation
window of JNK/SAPK signaling during the reprogramming pro-
cess and the outcome of JNK/SAPK downregulation in the
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reprogramming of both cell types were very similar, suggest-
ing that at least the JNK/SAPK functions related to reprogram-
ming are likely to be conserved in both cell types. Human
cord blood and hair follicle epithelial cells have emerged as
new sources of somatic cells for reprogramming because of
their accessibility. Recent reports suggest that JNK/SAPK sig-
naling is required in cord blood cells to prevent the onset of
senescence [35], while regulating apoptosis in hair follicle epi-
thelial cells [36]. While our experiments have only been per-
formed in dermal skin neonatal and adult fibroblasts thus
Figure 4. Inhibition of MKK4, MKK7 and JNK1 dependent signaling is detrimental for human induced pluripotent stem cells generation.
(A): Graphic representation of flow cytometric analysis on the different cellular subpopulations during reprogramming of MKK4, MKK7
and JNK1 deficient Neo1 fibroblasts. Results are presented as mean6 SEM (n5 3). *, p< .05. (B): Phase-contrast images of representa-
tive colonies arising during reprogramming of the control, MKK4- MKK7 and JNK1 deficient Neo1 fibroblasts. Scale bar5 100mm. (C):
Real-time quantitative RT-PCR analysis for ectoderm, mesoderm and endoderm markers at day 18 in JNK1 shRNA transduced cells. Data
represent relative expression to GAPDH and normalized against Control shRNA. Results are presented as average6 SEM (n5 3). Abbrevi-
ations: JNK, c-Jun N-terminal kinase; MKK, MAP kinase kinases; SAPK, stress-activated protein kinase; shRNA, short hairpin RNA.
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Figure 5. MKK4, MKK7 and JNK1 downregulation results in changes in the expression of key genes involved in cellular proliferation
and cell cycle progression. (A, B): Real-time quantitative PCR analysis of c-JUN, E2F2, ATF2 (A) and CDK6, CDK2, CDK1, CCND1 and
CCNB1 (B) in Control shRNA (Control) and MKK4, MKK7 and JNK1 deficient Neo1 fibroblasts at Day 1 of reprogramming. Results are pre-
sented as mean6 SEM (n5 3). *, p< .05. (C): Flow cytometric cell cycle analysis of MKK4, MKK7 and JNK1 shRNA treated fibroblasts
during the reprogramming process. Results are presented as mean6 SEM (n5 3). Abbreviations: JNK, c-Jun N-terminal kinase; MKK,
MAP kinase kinases; shRNA, short hairpin RNA.
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Figure 6. Downregulation of JNK1 expression results in disruption of the E-cadherin/b-Catenin network and increased N-Cadherin junc-
tional staining in emerging partially reprogrammed colonies. Double-immunofluorescence staining of transduced control and JNK1 defi-
cient Neo1 fibroblast for E-cadherin (A), b-Catenin (B) and N-cadherin (C) together with TRA1-60 (green) on day 18 post transduction
with OCT3/4, SOX2, KLF4, and c-MYC assessed by confocal microscope. Scale bars represent 50 mm. Images are representative of at least
three independent experiments. The percentage of double-positive colonies is shown on the top right hand corner of the merged
images. (D, D1): Real-time quantitative PCR analysis of SNAIL, ECAD, NCAD and TWIST, VIMENTIN, ZEB1 and SLUG at day18 of reprog-
ramming. Data represent relative expression to GAPDH and normalized against Control shRNA. Results are presented as mean6 SEM
(n5 3). *, p< .05. Abbreviations: JNK, c-Jun N-terminal kinase; shRNA, short hairpin RNA.
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preventing to make sound conclusions about the applicability
of our findings in other cell types, the well-known role of
JNK/SAPK signaling in maintaining cell survival and prolifera-
tion may suggest a critical role for this pathway during the
reprogramming process; however this has to be further inves-
tigated experimentally.
The functions of JNK/SAPK signaling are complex and
encompass a wide range of cellular processes which yield dif-
ferent outcomes in specific cell types [37]. Given the
increased expression of key components of JNK/SAPK signaling
during the initiation and maturation phases of reprogram-
ming, we sought to identify its involvement in several proc-
esses shown to be important during this time window namely
induction of MET [38], silencing of tumor suppressor and cell
cycle inhibitor genes [8], induction of apoptosis [39] and
induction of cell proliferation [40, 41]. Consistent with previ-
ous reports [42], we found that inhibition of JNK signaling did
not have any impact on the apoptosis of fibroblasts under-
going reprogramming (data not shown); hence the link
between apoptosis induction and JNK signaling can be
excluded. JNK signaling has been shown to be required for
the expression of c-Jun and JunD, two essential components
of the AP1 transcription factor which is essential for cell pro-
liferation and prevention of senescence often associated with
impaired JNK signaling [43]. Despite repeated investigations,
we did not observe expression of senescence associated b-
galactosidase in fibroblasts with deficient JNK signaling
achieved through chemical inhibition or RNAi. Neither did we
see an increase in the expression of cell cycle inhibitors
including p15, p16, p19 which have been linked to onset of
senescence in various cell types [44, 45]. These findings could
reflect differences in JNK outcomes in vivo versus in vitro
experiments (tissue culture) which have been reported previ-
ously, or the time lag that is needed from cell cycle arrest to
detectable expression of these markers. Despite lack of senes-
cence marker expression, we observed a significant decrease
in cellular proliferation, increased percentage of cells in G1
phase of the cell cycle at the expense of S phase and reduced
Figure 6. Continued
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expression of key cell cycle components involved in G1/S tran-
sition (such as CDK6, CDK2, CDK1, CCDN1) and S phase pro-
gression and G2/M transition (e.g., CCNB1). It is important to
note that such expression changes were specific for each
component of the JNK signaling pathway downregulated;
however in all cases simultaneous downregulation of at least
one CDK and one partnering Cyclin, an event that has been
shown to be important for efficient reprogramming [40] was
observed. These findings were further corroborated by
decreased expression of cellular proliferation markers c-Jun,
E2F2 and ATF2 in all three shRNA treated samples consistent
with previous reports indicating an important role for MKK4,
MKK7 and JNK1 for cell cycle progression [16, 46]. High cellu-
lar proliferation rate akin to ESC state is an important early
event for cellular reprogramming [40]. This leads us to suggest
that suppressed cellular proliferation and cell accumulation at
the G1 phase (both known as reprogramming barriers; [47])
at the onset of reprogramming of JNK1, MKK4 and MKK7 defi-
cient neonatal and adult fibroblasts is a key reason for the
complete lack of hiPSC observed during reprogramming of
these samples.
The efficiency of reprogramming can be promoted by
the onset of epithelial expression markers concomitantly
with the repression of mesenchymal markers in cells under-
going reprogramming during the 6th until the 12th day of
reprogramming, known as initiation phase [48, 49]. This is
precisely the window during which the JNK signaling is acti-
vated; hence we asked the question of whether MET transi-
tion is affected in JNK deficient cells. Our data suggest that
while control cells showed well organized TRA-1-
601 colonies characterized by plasma membrane staining of
E-cadherin and b-catenin indicating formation of adherent
junctions typical of epithelial cells, JNK deficient cells dis-
played a reduced percentage of cells expressing these
markers at both cellular and mRNA levels, which suggests
that fewer cells are able to undergo MET transition, thus
leading to inefficient reprogramming. Furthermore, the cel-
lular networks that guarantee cell-cell communication while
present and well organized in control cells were lacking in
JNK/SAPK deficient fibroblasts. It has been suggested that
expression of E-cadherin and the presence of intact adher-
ent junctions are essential for maintenance of pluripotency
in hESC by ensuring access to critical autocrine signals and
by promoting cell-cell exchange of signals through the gap
junctions [49, 50]. In this context, it is interesting to note
that all colonies that emerged during reprogramming of
JNK/SAPK deficient fibroblasts were partially reprogrammed
and completely disaggregated and subsequently lost during
the maturation stage of reprogramming thus leading us to
suggest that deficient JNK/SAPK signaling followed by
impaired cell to cell contact is likely to be one of the caus-
ative factor that counts for the partially reprogrammed phe-
notype and for the loss of colonies.
Our inhibition experiments were performed during the ini-
tiation stage of reprogramming. In all cases despite the time
of JNK/SAPK downregulation we obtained no hiPSC colonies.
However, we did not perform JNK/SAPK downregulation stud-
ies at the stabilization stage where hiPSC colonies are present
and continue to grow and develop. There were two main rea-
sons behind this decision: (1) JNK/SAPK activation occurs dur-
ing the initiation and maturation stage and shows a drop
during the stabilization stage and (2) our data presented in
this manuscript together with published reports indicate loss
of pluripotency in hESCs upon JNK downregulation [19], which
would suggest that downregulation of JNK/SAPK signaling
after the emergence of hiPSC colonies would result in their
differentiation and thus provide a further push toward loss of
true bona fide hiPSC colonies.
CONCLUSION
Together our data indicate an increase in JNK/SAPK activity
during the initiation and maturation phases of reprogramming
regardless of the reprogramming protocol and an indispensa-
ble role for the generation of hiPSC colonies. Furthermore,
we have shown that inhibition of JNK/SAPK signaling results
in reduced cell proliferation, disruption of MET and loss of
pluripotent phenotype which either singly or in combination
prevent establishment of pluripotent colonies as shown in the
summary (Fig. 7).
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